Dr. Mashal M. Alshazi

Dr. Mashal M. Alshazi, is an assistant professor of pharmaceutical biotechnology, Department of Pharmacology and Toxicology, College of pharmacy, King Saud University and Vice Director of the Infectious Diseases Vaccination Research Chair at King Saud University, Riyadh, Saudi Arabia. During 2017-2018, Dr. Alshazi was an employer of Department of Pediatrics National School of Tropical Medicine, Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development – Product Development Partnership. During his time at Center for Vaccine Development, Dr. Alshazi participated in development of vaccines against different infectious diseases including MERS-CoV and leishmaniasis. Prior joining KSU, Dr. Alshazi was working with AstraZeneca, Infection BioScience, Boston, USA. With AstraZeneca, he worked in development of different infection models. Dr. Alshazi holds a Ph.D. in Pharmaceutical Biotechnology from University of Illinois, USA, and a bachelor degree in Pharmaceutical Sciences from King Saud University. Dr. Alshazi is recipient of several scientific awards including Grand Challenges grant Award from Saudi Ministry of Education, Van Doren Scholar Award from University of Illinois, The American Society of Microbiology Award and RNA Society Award. Dr. Alshazi authored and co-authored several peer-reviewed articles, and supervised, co-supervised and examined a number of undergraduate and graduate students. He is a reviewer and editor for many reputable journals. He has organized conferences in the region related to vaccines and biologics with invited speakers from Europe and the United States. Dr. Alshazi is leading a research team that focused on mRNA and protein based vaccine development, antimicrobial resistance and antimicrobial drugs studies. Dr. Alshazi is working with several national and international bodies as vaccines and biologics consultant including Saudi Food and Drug Authority (SFDA) and Strategic Advisory Group (SAG), Ready2Respond.